These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1721390

  • 1. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
    Schmidt RJ, Venkat KK, Dumler F.
    Transplant Proc; 1991 Dec; 23(6):3156-7. PubMed ID: 1721390
    [No Abstract] [Full Text] [Related]

  • 2. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B, Abraham G, Srinivas CN, Bhaskar S.
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B, Ricou B, Suter PM.
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES, Thistlethwaite JR, Haas M, Josephson MA, Newell KA, Bruce DS, Millis JM, Piper JB, Charette JI.
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract] [Full Text] [Related]

  • 9. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
    Said T, al-Mousawi M, Samhan M, Lao M.
    Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
    Shapiro R, Jordan ML, Scantlebury VP, Fung JJ, Jensen C, Vivas C, McCauley J, Irish WD, Mitchell S, Demetris AJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):669-72. PubMed ID: 7679836
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
    Buturović J, Kandus A, Malovrh M, Bren A, Drinovec J.
    Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
    [No Abstract] [Full Text] [Related]

  • 14. Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.
    McCauley J, Shapiro R, Bronster O, Jordan M, Ellis D, Gilboa N, Scantlebury V, Jensen C, Jain A, Starzl T.
    Transplant Proc; 1991 Dec; 23(6):3068-70. PubMed ID: 1721362
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
    Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.
    Kaufman DB, Kaplan B, Kanwar YS, Abecassis M, Stuart FP.
    Transplantation; 1995 Jun 27; 59(12):1737-9. PubMed ID: 7541579
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.